Purine Analogues Increase the Risk of Lethal and/or Prolonged COVID19 While Obinutuzumab Increases the Risk of Prolonged but Not Lethal Infection in Patients Treated for Lymphoid Malignancies -a Study of Krohem, the Croatian Group for Hematologic Diseases

Patients with lymphoid malignancies are at increased risk of death due to COVID19. Currently, it is not completely clear whether this is mainly due to disease biology or to anti-lymphoma treatment and whether the prognosis of infection differs in patients treated with different therapies. Anti-CD20...

Descripción completa

Detalles Bibliográficos
Autores principales: Aurer, Igor, Jaksic, Ozren, Bašić-Kinda, Sandra, Mrdenovic, Stefan, Ostojic Kolonic, Slobodanka, Lozic, Dominik, Holik, Hrvoje, Novakovic Coha, Sabina, Bernes, Petra, Krecak, Ivan, Moric Peric, Martina, Narancic, Marino, Mitrovic, Zdravko, Valkovic, Toni
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Hematology. Published by Elsevier Inc. 2021
Materias:
623.Mantle Cell, Follicular, and Other Indolent B Cell Lymphomas: Clinical and Epidemiological
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8701423/
http://dx.doi.org/10.1182/blood-2021-149613

Ejemplares similares

Ejemplares similares